Ledger.Open graph →
SEC Form D · Amendment · filed April 22, 2019

OncoNano Medicine, Inc

Offering
$35.4M
Sold
$33.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Southlake, TX
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Matthew Head · Southlake, TXExecJoydeep Goswami · Southlake, TXDirectorRavi Srinivasan · Southlake, TXExec · DirectorJohn Dyett · Southlake, TXDirectorAlvaro Guillem · Southlake, TXDirectorBronwyn Wright · Dublin 2, IrelandExecTara Iii LLC · Santa Monica, CADirectorWalter J. Novicki · Fort Myers, FLDirectorNoel Ford · Dublin 2, IrelandDirectorBenjamin Pass · New York, NYExec · DirectorParitosh Dhawale · Dallas, TXDirectorAshish P. Sanghrajka · New York, NYDirectorEric W. Chan · San Francisco, CADirectorPaul J. Hopper · New York, NYExecJeffrey R. Bartfeld · San Francisco, CADirectorBryan Gammon · Austin, TXExec · DirectorParitosh Dhawale · Dallas, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗